Palvella Therapeutics (PVLA) Change in Acquisitions & Divestments (2018 - 2024)
Historic Change in Acquisitions & Divestments for Palvella Therapeutics (PVLA) over the last 6 years, with Q1 2024 value amounting to $9.0 million.
- Palvella Therapeutics' Change in Acquisitions & Divestments fell 3330.86% to $9.0 million in Q1 2024 from the same period last year, while for Sep 2024 it was $20.0 million, marking a year-over-year decrease of 3400.53%. This contributed to the annual value of $35.0 million for FY2023, which is 2414.18% up from last year.
- Latest data reveals that Palvella Therapeutics reported Change in Acquisitions & Divestments of $9.0 million as of Q1 2024, which was down 3330.86% from $11.0 million recorded in Q4 2023.
- In the past 5 years, Palvella Therapeutics' Change in Acquisitions & Divestments ranged from a high of $28.4 million in Q1 2020 and a low of $4.8 million during Q2 2022
- Its 4-year average for Change in Acquisitions & Divestments is $13.0 million, with a median of $12.2 million in 2023.
- In the last 5 years, Palvella Therapeutics' Change in Acquisitions & Divestments skyrocketed by 91091.14% in 2020 and then plummeted by 7001.76% in 2023.
- Palvella Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $15.8 million in 2020, then tumbled by 60.0% to $6.3 million in 2022, then soared by 74.62% to $11.0 million in 2023, then decreased by 18.19% to $9.0 million in 2024.
- Its last three reported values are $9.0 million in Q1 2024, $11.0 million for Q4 2023, and $5.1 million during Q3 2023.